Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms

References

• Abbas, A. M. 2016. Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. Journal of Physiology and Biochemistry 72 (3):469–84.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B. B., A. Kumar, and A. C. Bharti. 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research 23 (1A):363–98.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B. B., Y.-J. Surh, and S. Shishodia. 2007. The molecular targets and therapeutic uses of curcumin in health and disease. Springer Science & Business Media.
   Google Scholar
• Al Makdessi, S., J. L. Andrieu, H. Herilier, and G. Faucon. 1987. Effect of isoproterenol on the metabolism of myocardial fatty acids. Journal of Molecular and Cellular Cardiology 19 (2):141–9. doi: 10.1016/S0022-2828(87)80556-4.
   PubMed Web of Science ®Google Scholar
• Allijn, I. E., B. M. S. Czarny, X. Wang, S. Y. Chong, M. Weiler, A. E. da Silva, J. M. Metselaar, C. S. P. Lam, G. Pastorin, D. P. V. de Kleijn, et al. 2017. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. Journal of Controlled Release: Official Journal of the Controlled Release Society 247:127–33.
   PubMed Web of Science ®Google Scholar
• Amadio, P., G. I. Colombo, E. Tarantino, S. Gianellini, A. Ieraci, M. Brioschi, C. Banfi, J. P. Werba, A. Parolari, F. S. Lee, et al. 2017. BDNFVal66met polymorphism: A potential bridge between depression and thrombosis. European Heart Journal 38 (18):1426–35.
   PubMed Web of Science ®Google Scholar
• Anand, P., A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal. 2007. Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics 4 (6):807–18.
   PubMed Web of Science ®Google Scholar
• Annapurna, A.,. C. S. Reddy, R. B. Akondi, and S. R. Rao. 2009. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. The Journal of Pharmacy and Pharmacology 61 (10):1365–74.
   PubMed Web of Science ®Google Scholar
• Arakelyan, A., J. Petrkova, Z. Hermanova, A. Boyajyan, J. Lukl, and M. Petrek. 2005. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators of Inflammation 2005 (3):175–9. doi: 10.1155/MI.2005.175.
   PubMedGoogle Scholar
• Bagherian, A., R. Mardani, B. Roudi, M. Taghizadeh, H. R. Banfshe, A. Ghaderi, A. Davoodvandi, S. Shamollaghamsari, M. R. Hamblin, and H. Mirzaei. 2020. Combination therapy with nanomicellar-curcumin and temozolomide for in vitro therapy of glioblastoma multiforme via wnt signaling pathways. Journal of Molecular Neuroscience : MN 70 (10):1471–83.
   PubMed Web of Science ®Google Scholar
• Bagherian, A., B. Roudi, N. Masoudian, and H. Mirzaei. 2021. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib. Food & Function 12 (21):10926–37.
   PubMed Web of Science ®Google Scholar
• Bak, I., I. Lekli, B. Juhasz, N. Nagy, E. Varga, J. Varadi, R. Gesztelyi, G. Szabo, L. Szendrei, I. Bacskay, et al. 2006. Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts. American Journal of Physiology-Heart and Circulatory Physiology 291 (3):H1329–1336. doi: 10.1152/ajpheart.01243.2005.
   PubMed Web of Science ®Google Scholar
• Baltruskeviciene, E., D. Schveigert, V. Stankevicius, U. Mickys, T. Zvirblis, J. Bublevic, K. Suziedelis, and E. Aleknavicius. 2017. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. BMC Cancer 17 (1):607.
   PubMedGoogle Scholar
• Bash-Imam, Z., G. Thérizols, A. Vincent, F. Lafôrets, M. Polay Espinoza, N. Pion, F. Macari, J. Pannequin, A. David, J. C. Saurin, et al. 2017. Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism. Oncotarget 8 (28):46219–33.
   PubMedGoogle Scholar
• Battu, S. K., M. A. Repka, S. Maddineni, A. G. Chittiboyina, M. A. Avery, and S. Majumdar. 2010. Physicochemical characterization of berberine chloride: A perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech 11 (3):1466–75. doi: 10.1208/s12249-010-9520-y.
   PubMed Web of Science ®Google Scholar
• Bayraktar, R., and K. Van Roosbroeck. 2018. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. Cancer Metastasis Reviews 37 (1):33–44.
   PubMed Web of Science ®Google Scholar
• Bhardwaj, A., H. Singh, K. Rajapakshe, K. Tachibana, N. Ganesan, Y. Pan, P. H. Gunaratne, C. Coarfa, and I. Bedrosian. 2017. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer. Oncotarget 8 (12):19645–60.
   PubMedGoogle Scholar
• Bierhoff, H., K. Schmitz, F. Maass, J. Ye, and I. Grummt. 2010. Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harbor Symposia on Quantitative Biology 75 (0):357–64. doi: 10.1101/sqb.2010.75.060.
   PubMedGoogle Scholar
• Blanca, A., L. Cheng, R. Montironi, H. Moch, F. Massari, M. Fiorentino, M. R. Raspollini, M. Scarpelli, and A. Lopez-Beltran. 2017. Mirna expression in bladder cancer and their potential role in clinical practice. Current Drug Metabolism 18 (8):712–22.
   PubMed Web of Science ®Google Scholar
• Boarescu, P. M., I. Boarescu, I. C. Bocsan, D. Gheban, A. E. Bulboaca, C. Nicula, R. M. Pop, R. M. Rajnoveanu, and S. D. Bolboaca. 2019. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants (Basel ). 8. doi: 10.3390/antiox8100504.
   PubMedGoogle Scholar
• Boarescu, P. M., I. Boarescu, I. C. Bocsan, R. M. Pop, D. Gheban, A. E. Bulboaca, C. Nicula, and R. M. Rajnoveanu. 2019. Curcumin nanoparticles protect against isoproterenol induced myocardial infarction by alleviating myocardial tissue oxidative stress. Electrocardiogram, and Biological Changes 24.
   Google Scholar
• Boarescu, P.-M., I. Chirilă, A. E. Bulboacă, I. C. Bocșan, R. M. Pop, D. Gheban, and S. D. Bolboacă. 2019. Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction. Oxidative Medicine and Cellular Longevity 2019:7847142. doi: 10.1155/2019/7847142.
   PubMed Web of Science ®Google Scholar
• Braicu, O. L., L. Budisan, R. Buiga, A. Jurj, P. Achimas-Cadariu, L. A. Pop, C. Braicu, A. Irimie, and I. Berindan-Neagoe. 2017. miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. OncoTargets and Therapy Volume 10:4225–38. doi: 10.2147/OTT.S137107.
   Web of Science ®Google Scholar
• Brower, G. L., J. D. Gardner, M. F. Forman, D. B. Murray, T. Voloshenyuk, S. P. Levick, and J. S. Janicki. 2006. The relationship between myocardial extracellular matrix remodeling and ventricular function. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 30 (4):604–10.
   PubMed Web of Science ®Google Scholar
• Brunner, S., J. Winogradow, B. C. Huber, M. M. Zaruba, R. Fischer, R. David, G. Assmann, N. Herbach, R. Wanke, J. Mueller-Hoecker, et al. 2009. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB Journal : official Publication of the Federation of American Societies for Experimental Biology 23 (2):351–61. doi: 10.1096/fj.08-109462.
   PubMed Web of Science ®Google Scholar
• Burstein, B.,. A. Maguy, R. Clement, H. Gosselin, F. Poulin, N. Ethier, J. C. Tardif, T. E. Hebert, A. Calderone, and S. Nattel. 2007. Effects of resveratrol (trans-3,5,4’-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction. The Journal of Pharmacology and Experimental Therapeutics 323 (3):916–23.
   PubMed Web of Science ®Google Scholar
• Chang, W., K. Li, F. Guan, F. Yao, Y. Yu, M. Zhang, G. M. Hatch, and L. Chen. 2016. Berberine pretreatment confers cardioprotection against ischemia-reperfusion injury in a rat model of Type 2 diabetes. Journal of Cardiovascular Pharmacology and Therapeutics 21 (5):486–94. doi: 10.1177/1074248415627873.
   PubMed Web of Science ®Google Scholar
• Chang, W., M. Zhang, J. Li, Z. Meng, D. Xiao, S. Wei, L. Chen, C. Wang, and G. M. Hatch. 2012. Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5’-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart. Cardiovascular Drugs and Therapy 26 (6):467–78. doi: 10.1007/s10557-012-6422-0.
   PubMed Web of Science ®Google Scholar
• Cheng, T. O. 2007. Cardiovascular effects of Danshen. International Journal of Cardiology 121 (1):9–22. doi: 10.1016/j.ijcard.2007.01.004.
   PubMed Web of Science ®Google Scholar
• Chen, W., F. Tang, B. Xie, S. Chen, H. Huang, and P. Liu. 2012. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. European Journal of Pharmacology 674 (2-3):359–64.
   PubMed Web of Science ®Google Scholar
• Chen, Y. R., F. F. Yi, X. Y. Li, C. Y. Wang, L. Chen, X. C. Yang, P. X. Su, and J. Cai. 2008. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovascular Drugs and Therapy 22 (6):479–85. doi: 10.1007/s10557-008-6141-8.
   PubMed Web of Science ®Google Scholar
• Chien, K. R., J. Abrams, A. Serroni, J. T. Martin, and J. L. Farber. 1978. Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. The Journal of Biological Chemistry 253 (13):4809–17.
   PubMed Web of Science ®Google Scholar
• Clerk, A., T. J. Kemp, G. Zoumpoulidou, and P. H. Sugden. 2007. Cardiac myocyte gene expression profiling during H2O2-induced apoptosis. Physiological Genomics 29 (2):118–27. doi: 10.1152/physiolgenomics.00168.2006.
   PubMed Web of Science ®Google Scholar
• Cong, X., Y. Li, N. Lu, Y. Dai, H. Zhang, X. Zhao, and Y. Liu. 2014. Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart. Molecular Medicine Reports 9 (6):2528–32.
   PubMed Web of Science ®Google Scholar
• Costa, F. F. 2010. Non-coding RNAs: Meet thy masters. BioEssays : news and Reviews in Molecular, Cellular and Developmental Biology 32 (7):599–608.
   PubMed Web of Science ®Google Scholar
• Das, S., V. K. Alagappan, D. Bagchi, H. S. Sharma, N. Maulik, and D. K. Das. 2005. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascular Pharmacology 42 (5/6):281–9.
   PubMed Web of Science ®Google Scholar
• Das, S., G. A. Cordis, N. Maulik, and D. K. Das. 2005. Pharmacological preconditioning with resveratrol: Role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. American Journal of Physiology. Heart and Circulatory Physiology 288 (1):H328–335.
   PubMed Web of Science ®Google Scholar
• Das, S., A. Tosaki, D. Bagchi, N. Maulik, and D. K. Das. 2006. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. The Journal of Pharmacology and Experimental Therapeutics 317 (3):980–8. doi: 10.1124/jpet.105.095133.
   PubMed Web of Science ®Google Scholar
• Dekkers, D. H., K. Bezstarosti, N. Gurusamy, K. Luijk, A. J. Verhoeven, E. J. Rijkers, J. A. Demmers, J. M. Lamers, N. Maulik, and D. K. Das. 2008. Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart. Journal of Cellular and Molecular Medicine 12 (5A):1677–89.
   PubMed Web of Science ®Google Scholar
• Delucchi, F., R. Berni, C. Frati, S. Cavalli, G. Graiani, R. Sala, C. Chaponnier, G. Gabbiani, L. Calani, D. Del Rio, et al. 2012. Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats. PLoS One 7 (6):e39836.
   PubMed Web of Science ®Google Scholar
• Deng, Q., J. Liu, Q. Li, K. Chen, Z. Liu, Y. Shen, P. Niu, Y. Yang, Y. Zou, and X. Yang. 2013. Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environmental Health 12 (1):30. doi: 10.1186/1476-069X-12-30.
   PubMedGoogle Scholar
• Deng, M., D. Wang, S. He, R. Xu, and Y. Xie. 2017. SIRT1 confers protection against ischemia/reperfusion injury in cardiomyocytes via regulation of uncoupling protein 2 expression. Molecular Medicine Reports 16 (5):7098–104.
   PubMed Web of Science ®Google Scholar
• Dewald, O., P. Zymek, K. Winkelmann, A. Koerting, G. Ren, T. Abou-Khamis, L. H. Michael, B. J. Rollins, M. L. Entman, and N. G. Frangogiannis. 2005. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circulation Research 96 (8):881–9.
   PubMed Web of Science ®Google Scholar
• Dhalla, N. S., R. M. Temsah, and T. Netticadan. 2000. Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 18 (6):655–73. doi: 10.1097/00004872-200018060-00002.
   PubMed Web of Science ®Google Scholar
• Downey, J. M., and M. V. Cohen. 2009. Why do we still not have cardioprotective drugs? Circulation Journal 73 (7):1171–7. doi: 10.1253/circj.CJ-09-0338.
   PubMed Web of Science ®Google Scholar
• Eleawa, S. M., M. Alkhateeb, S. Ghosh, F. Al-Hashem, A. S. Shatoor, A. Alhejaily, and M. A. Khalil. 2015. Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats. International Journal of Physiology, Pathophysiology and Pharmacology 7 (1):1–13.
   PubMedGoogle Scholar
• Feng, L., J. Ren, Y. Li, G. Yang, L. Kang, S. Zhang, C. Ma, J. Li, J. Liu, L. Yang, et al. 2019. Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway. Free Radical Research 53 (1):82–93.
   PubMed Web of Science ®Google Scholar
• Fisch, S., S. Gray, S. Heymans, S. M. Haldar, B. Wang, O. Pfister, L. Cui, A. Kumar, Z. Lin, S. Sen-Banerjee, et al. 2007. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 104 (17):7074–9.
   PubMed Web of Science ®Google Scholar
• Fourny, N., C. Lan, E. Seree, M. Bernard, and M. Desrois. 2019. Protective effect of resveratrol against ischemia-reperfusion injury via enhanced high energy compounds and eNOS-SIRT1 expression in Type 2 diabetic female rat heart. Nutrients 11 (1):105. doi: 10.3390/nu11010105.
   PubMed Web of Science ®Google Scholar
• Frati, G., U. Benedetto, G. Biondi-Zoccai, and S. Sciarretta. 2015. Bridging the gap between translational and outcome research in cardiovascular disease. BioMed Research International 2015:454680.
   PubMed Web of Science ®Google Scholar
• Fujisawa, S., T. Atsumi, M. Ishihara, and Y. Kadoma. 2004. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Research 24 (2B):563–70.
   PubMed Web of Science ®Google Scholar
• Fukuda, S., S. Kaga, L. Zhan, D. Bagchi, D. K. Das, A. Bertelli, and N. Maulik. 2006. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochemistry and Biophysics 44 (1):43–9.
   PubMed Web of Science ®Google Scholar
• Gallagher, G.,. S. Menzie, Y. Huang, C. Jackson, and S. N. Hunyor. 2007. Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep. Basic Research in Cardiology 102 (1):63–72. doi: 10.1007/s00395-006-0610-7.
   PubMed Web of Science ®Google Scholar
• Gao, S., Z. Liu, H. Li, P. J. Little, P. Liu, and S. Xu. 2012. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 220 (1):3–10.
   PubMed Web of Science ®Google Scholar
• Gu, X. S., Z. B. Wang, Z. Ye, J. P. Lei, L. Li, D. F. Su, and X. Zheng. 2014. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genetics and Molecular Research : GMR 13 (1):323–35.
   PubMed Web of Science ®Google Scholar
• Gupta, S. C., S. Prasad, J. H. Kim, S. Patchva, L. J. Webb, I. K. Priyadarsini, and B. B. Aggarwal. 2011. Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports 28 (12):1937–55.
   PubMed Web of Science ®Google Scholar
• Guttman, M., and J. L. Rinn. 2012. Modular regulatory principles of large non-coding RNAs. Nature 482 (7385):339–46.
   PubMed Web of Science ®Google Scholar
• Hayashidani, S., H. Tsutsui, T. Shiomi, M. Ikeuchi, H. Matsusaka, N. Suematsu, J. Wen, K. Egashira, and A. Takeshita. 2003. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108 (17):2134–40. doi: 10.1161/01.CIR.0000092890.29552.22.
   PubMed Web of Science ®Google Scholar
• Higashi, Y., K. Noma, M. Yoshizumi, and Y. Kihara. 2009. Endothelial function and oxidative stress in cardiovascular diseases. Circulation Journal : official Journal of the Japanese Circulation Society 73 (3):411–8. doi: 10.1253/circj.cj-08-1102.
   PubMed Web of Science ®Google Scholar
• Holder, G. M., J. L. Plummer, and A. J. Ryan. 1978. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8 (12):761–8. doi: 10.3109/00498257809069589.
   PubMed Web of Science ®Google Scholar
• Hong, Y., S. C. Hui, T. Y. Chan, and J. Y. Hou. 2002. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. The American Journal of Chinese Medicine 30 (04):589–99. doi: 10.1142/S0192415X02000612.
   PubMedGoogle Scholar
• Hong, Y., S. S. Hui, B. T. Chan, and J. Hou. 2003. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sciences 72 (22):2499–507.
   PubMed Web of Science ®Google Scholar
• Hong, W., S. Tatsuo, W. Shou-Dong, Z. Qian, H. Jian-Feng, W. Jue, J. Chen, Q. Hai-Yan, and Y. Yue-Jin. 2015. Resveratrol upregulates cardiac SDF-1 in mice with acute myocardial infarction through the deacetylation of Cardiac p53. PLoS One 10 (6):e0128978.
   PubMed Web of Science ®Google Scholar
• Hong, D., X. Zeng, W. Xu, J. Ma, Y. Tong, and Y. Chen. 2010. Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarction. Pharmacological Research 61 (2):142–8.
   PubMed Web of Science ®Google Scholar
• Hsu, C. P., P. Zhai, T. Yamamoto, Y. Maejima, S. Matsushima, N. Hariharan, D. Shao, H. Takagi, S. Oka, and J. Sadoshima. 2010. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122 (21):2170–82. doi: 10.1161/CIRCULATIONAHA.110.958033.
   PubMed Web of Science ®Google Scholar
• Huang, P., S. M. Riordan, D. P. Heruth, D. N. Grigoryev, L. Q. Zhang, and S. Q. Ye. 2015. A critical role of nicotinamide phosphoribosyltransferase in human telomerase reverse transcriptase induction by resveratrol in aortic smooth muscle cells. Oncotarget 6 (13):10812–24.
   PubMedGoogle Scholar
• Huang, Z. J., Y. Zeng, P. Lan, P. H. Sun, and W. M. Chen. 2011. Advances in structural modifications and biological activities of berberine: An active compound in traditional Chinese medicine. Mini Reviews in Medicinal Chemistry 11 (13):1122–9.
   PubMed Web of Science ®Google Scholar
• Ilkun, O., and S. Boudina. 2013. Cardiac dysfunction and oxidative stress in the metabolic syndrome: An update on antioxidant therapies. Current Pharmaceutical Design 19 (27):4806–17. doi: 10.2174/1381612811319270003.
   PubMed Web of Science ®Google Scholar
• Imamura, G., A. A. Bertelli, A. Bertelli, H. Otani, N. Maulik, and D. K. Das. 2002. Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. American Journal of Physiology. Heart and Circulatory Physiology 282 (6):H1996–2003.
   PubMed Web of Science ®Google Scholar
• Iuga, C., J. R. Alvarez-Idaboy, and N. Russo. 2012. Antioxidant activity of trans-resveratrol toward hydroxyl and hydroperoxyl radicals: A quantum chemical and computational kinetics study. The Journal of Organic Chemistry 77 (8):3868–77. doi: 10.1021/jo3002134.
   PubMed Web of Science ®Google Scholar
• Jayachandran, M., S. S. M. Chung, and B. Xu. 2020. A critical review on diet-induced microbiota changes and cardiovascular diseases. Critical Reviews in Food Science and Nutrition 60 (17):2914–25.
   PubMed Web of Science ®Google Scholar
• Jin, U. H., S. J. Suh, H. W. Chang, J. K. Son, S. H. Lee, K. H. Son, Y. C. Chang, and C. H. Kim. 2008. Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP‐9 activity through AKT signaling pathway. Journal of Cellular Biochemistry 104 (1):15–26.
   PubMed Web of Science ®Google Scholar
• Jin, H. B., Y. B. Yang, Y. L. Song, Y. C. Zhang, and Y. R. Li. 2012. Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats. Molecular Biology Reports 39 (12):11005–9. doi: 10.1007/s11033-012-2002-4.
   PubMed Web of Science ®Google Scholar
• Kanamori, H., G. Takemura, K. Goto, A. Tsujimoto, A. Ogino, T. Takeyama, T. Kawaguchi, T. Watanabe, K. Morishita, M. Kawasaki, et al. 2013. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. The American Journal of Pathology 182 (3):701–13.
   PubMed Web of Science ®Google Scholar
• Kasim, N. A., M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernäs, A. S. Hussain, H. E. Junginger, S. A. Stavchansky, K. K. Midha, V. P. Shah, et al. 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Molecular Pharmaceutics 1 (1):85–96. doi: 10.1021/mp034006h.
   PubMed Web of Science ®Google Scholar
• Kawaji, H., and Y. Hayashizaki. 2008. Exploration of small RNAs. PLoS Genetics 4 (1):e22. doi: 10.1371/journal.pgen.0040022.
   PubMed Web of Science ®Google Scholar
• Kazemzadeh, M., R. Safaralizadeh, and A. V. Orang. 2015. LncRNAs: Emerging players in gene regulation and disease pathogenesis. Journal of Genetics 94 (4):771–84.
   PubMed Web of Science ®Google Scholar
• Kim, D. H., S. Kim, S. J. Jeon, K. H. Son, S. Lee, B. H. Yoon, J. H. Cheong, K. H. Ko, and J. H. Ryu. 2009. Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signalling pathway. British Journal of Pharmacology 158 (4):1131–42.
   PubMed Web of Science ®Google Scholar
• Kobusiak-Prokopowicz, M., J. Orzeszko, G. Mazur, A. Mysiak, A. Orda, R. Poreba, and W. Mazurek. 2007. Chemokines and left ventricular function in patients with acute myocardial infarction. European Journal of Internal Medicine 18 (4):288–94. doi: 10.1016/j.ejim.2007.02.001.
   PubMed Web of Science ®Google Scholar
• Kohno, T., T. Anzai, K. Naito, Y. Sugano, Y. Maekawa, T. Takahashi, T. Yoshikawa, and S. Ogawa. 2008. Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. Circulation Journal : Official Journal of the Japanese Circulation Society 72 (10):1685–92. doi: 10.1253/circj.CJ-08-0115.
   PubMed Web of Science ®Google Scholar
• Kong, W., J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, et al. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine 10 (12):1344–51.
   PubMed Web of Science ®Google Scholar
• Kumar, M., E. R. Kasala, L. N. Bodduluru, V. Kumar, and M. Lahkar. 2017. Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats. Journal of Biochemical and Molecular Toxicology 31 (1):1–8.
   PubMed Web of Science ®Google Scholar
• Kumari, S. S., A. Jayadeep, J. S. Kumar, and V. Menon. 1989. Effects of carnitine on malondialdehyde, taurine, glutathione levels in heart of rats subjected to myocardial stress by isoproterenol. Indian Journal of Experimental Biology 27 (2):134–7.
   PubMed Web of Science ®Google Scholar
• Lai, Y., S. He, L. Ma, H. Lin, B. Ren, J. Ma, X. Zhu, and S. Zhuang. 2017. HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy. Molecular and Cellular Biochemistry 432 (1-2):179–87.
   PubMed Web of Science ®Google Scholar
• Lakhanpal, P., and D. K. Rai. 2007. Quercetin: A versatile flavonoid. Internet Journal of Medical Update 2:22–37.
   Google Scholar
• Lakhotia, S. C. 2012. Long non‐coding RNAs coordinate cellular responses to stress. Wiley Interdisciplinary Reviews. RNA 3 (6):779–96.
   PubMed Web of Science ®Google Scholar
• Lam, B., A. Lo, X. Sun, H. Luo, S. Chung, and N. Sucher. 2003. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 10 (4):286–91.
   PubMed Web of Science ®Google Scholar
• Lee, J.-C., J. H. Park, O. K. Park, I. H. Kim, B. C. Yan, J. H. Ahn, S.-H. Kwon, J. H. Choi, J.-D. Kim, and M.-H. Won. 2013. Neuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemia. Anatomy & Cell Biology 46 (3):183–90. doi: 10.5115/acb.2013.46.3.183.
   PubMedGoogle Scholar
• Leenders, J. J., W. J. Wijnen, I. van der Made, M. Hiller, M. Swinnen, T. Vandendriessche, M. Chuah, Y. M. Pinto, and E. E. Creemers. 2012. Repression of cardiac hypertrophy by KLF15: Underlying mechanisms and therapeutic implications. PLoS One 7 (5):e36754. doi: 10.1371/journal.pone.0036754.
   PubMed Web of Science ®Google Scholar
• Lekli, I., D. Ray, S. Mukherjee, N. Gurusamy, M. K. Ahsan, B. Juhasz, I. Bak, A. Tosaki, M. Gherghiceanu, L. M. Popescu, et al. 2010. Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. Journal of Cellular and Molecular Medicine 14 (10):2506–18.
   PubMed Web of Science ®Google Scholar
• Lekli, I., G. Szabo, B. Juhasz, S. Das, M. Das, E. Varga, L. Szendrei, R. Gesztelyi, J. Varadi, I. Bak, et al. 2008. Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: The role of GLUT-4 and endothelin. American Journal of Physiology. Heart and Circulatory Physiology 294 (2):H859–866.
   PubMed Web of Science ®Google Scholar
• Liao, Y., K. Chen, X. Dong, W. Li, G. Li, G. Huang, W. Song, L. Chen, and Y. Fang. 2018. Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats. Experimental and Therapeutic Medicine 16 (3):2499–505.
   PubMed Web of Science ®Google Scholar
• Liao, Z., D. Liu, L. Tang, D. Yin, S. Yin, S. Lai, J. Yao, and M. He. 2015. Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: Involvement of VDAC1 downregulation. Molecular Nutrition & Food Research 59 (3):454–64. doi: 10.1002/mnfr.201400730.
   PubMed Web of Science ®Google Scholar
• Li, N., X. Chen, J. Liao, G. Yang, S. Wang, Y. Josephson, C. Han, J. Chen, M. T. Huang, and C. S. Yang. 2002. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23 (8):1307–13. doi: 10.1093/carcin/23.8.1307.
   PubMed Web of Science ®Google Scholar
• Li, H. L., C. Liu, G. de Couto, M. Ouzounian, M. Sun, A. B. Wang, Y. Huang, C. W. He, Y. Shi, X. Chen, et al. 2008. Curcumin prevents and reverses murine cardiac hypertrophy. The Journal of Clinical Investigation 118 (3):879–93.
   PubMed Web of Science ®Google Scholar
• Lim, S. Y., S. M. Davidson, D. J. Hausenloy, and D. M. Yellon. 2007. Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore. Cardiovascular Research 75 (3):530–5. doi: 10.1016/j.cardiores.2007.04.022.
   PubMed Web of Science ®Google Scholar
• Ling, L., S. Gu, and Y. Cheng. 2017. Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction. Molecular Medicine Reports 15 (3):1188–94. doi: 10.3892/mmr.2017.6143.
   PubMed Web of Science ®Google Scholar
• Lin, J. F., S. M. Lin, C. L. Chih, M. W. Nien, H. H. Su, B. R. Hu, S. S. Huang, and S. K. Tsai. 2008. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sciences 83 (9/10):313–7.
   PubMed Web of Science ®Google Scholar
• Lin, J. F., S. Wu, S. S. Huang, B. Y. Lu, S. M. Lin, and S. K. Tsai. 2011. Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction. The Chinese Journal of Physiology 54 (6):406–12.
   PubMed Web of Science ®Google Scholar
• Liu, S., Y. Du, K. Shi, Y. Yang, and Z. Yang. 2019. Resveratrol improves cardiac function by promoting M2-like polarization of macrophages in mice with myocardial infarction. American Journal of Translational Research 11 (8):5212–26.
   PubMed Web of Science ®Google Scholar
• Liu, X., D. Li, W. Zhang, M. Guo, and Q. Zhan. 2012. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. The EMBO Journal 31 (23):4415–27.
   PubMed Web of Science ®Google Scholar
• Liu, Z., J. Wang, E. Huang, S. Gao, H. Li, J. Lu, K. Tian, P. J. Little, X. Shen, S. Xu, et al. 2014. Tanshinone IIA suppresses cholesterol accumulation in human macrophages: Role of heme oxygenase-1 [S]. Journal of Lipid Research 55 (2):201–13.
   PubMed Web of Science ®Google Scholar
• Liu, H., C. Wang, Z. Qiao, and Y. Xu. 2017. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharmaceutical Biology. 55:1144–8.
   PubMed Web of Science ®Google Scholar
• Liu, W., Y. Zhai, X. Heng, F. Y. Che, W. Chen, D. Sun, and G. Zhai. 2016. Oral bioavailability of curcumin: Problems and advancements. Journal of Drug Targeting 24 (8):694–702.
   PubMed Web of Science ®Google Scholar
• Liu, Q-y, Z-h Zhang, X. Jin, Y.-R. Jiang, and X.-B. Jia. 2013. Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan. The Journal of Pharmacy and Pharmacology 65 (6):839–46.
   PubMed Web of Science ®Google Scholar
• Liu, L.,. X. Zhang, L. Wang, R. Yang, L. Cui, M. Li, W. Du, and S. Wang. 2010. The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke. Brain Research Bulletin 82 (3-4):228–33. doi: 10.1016/j.brainresbull.2010.04.005.
   PubMed Web of Science ®Google Scholar
• Li, Z. M., S. W. Xu, and P. Q. Liu. 2018. Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics. Acta Pharmacologica Sinica 39 (5):802–24.
   PubMed Web of Science ®Google Scholar
• Li, B., M. Yang, J. W. Liu, and G. T. Yin. 2016. Protective mechanism of quercetin on acute myocardial infarction in rats. Genetics and Molecular Research 15:15017117.
   PubMed Web of Science ®Google Scholar
• Li, B. X., B. F. Yang, J. Zhou, C. Q. Xu, and Y. R. Li. 2001. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes. Acta Pharmacologica Sinica 22:125–31.
   PubMed Web of Science ®Google Scholar
• Luo, Y., D.-Q. Xu, H.-Y. Dong, B. Zhang, Y. Liu, W. Niu, M.-Q. Dong, and Z.-C. Li. 2013. Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway. PLoS One 8 (2):e56774.
   PubMed Web of Science ®Google Scholar
• Lv, F. H., H. L. Yin, Y. Q. He, H. M. Wu, J. Kong, X. Y. Chai, and S. R. Zhang. 2016. Effects of curcumin on the apoptosis of cardiomyocytes and the expression of NF-kappaB, PPAR-gamma and Bcl-2 in rats with myocardial infarction injury. Experimental and Therapeutic Medicine 12 (6):3877–84. doi: 10.3892/etm.2016.3858.
   PubMed Web of Science ®Google Scholar
• Magyar, K., R. Halmosi, A. Palfi, G. Feher, L. Czopf, A. Fulop, I. Battyany, B. Sumegi, K. Toth, and E. Szabados. 2012. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clinical Hemorheology and Microcirculation 50 (3):179–87. doi: 10.3233/CH-2011-1424.
   PubMed Web of Science ®Google Scholar
• Ma, C., Y. Jiang, X. Zhang, X. Chen, Z. Liu, and X. Tian. 2018. Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway. Molecular Medicine Reports 17 (5):6675–80.
   PubMed Web of Science ®Google Scholar
• Malhotra, A., S. Bath, and F. Elbarbry. 2015. An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxidative Medicine and Cellular Longevity 2015:803971.
   PubMed Web of Science ®Google Scholar
• Ma, P., J. Liu, C. Zhang, and Z. Liang. 2013. Regulation of water-soluble phenolic acid biosynthesis in Salvia miltiorrhiza Bunge. Applied Biochemistry and Biotechnology 170 (6):1253–62.
   PubMed Web of Science ®Google Scholar
• Mao, S., L. Wang, P. Chen, Y. Lan, R. Guo, and M. Zhang. 2018. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: Role of NF-kappaB pathway. Artificial Cells, Nanomedicine, and Biotechnology. 46 (sup3):S707–s716. doi: 10.1080/21691401.2018.1508028.
   PubMed Web of Science ®Google Scholar
• Marczylo, T. H., R. D. Verschoyle, D. N. Cooke, P. Morazzoni, W. P. Steward, and A. J. Gescher. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemotherapy and Pharmacology 60 (2):171–7.
   PubMed Web of Science ®Google Scholar
• Mardani, R., M. R. Hamblin, M. Taghizadeh, H. R. Banafshe, M. Nejati, M. Mokhtari, S. Borran, A. Davoodvandi, H. Khan, M. R. Jaafari, et al. 2020. Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis. Pathology, Research and Practice 216 (9):153082. doi: 10.1016/j.prp.2020.153082.
   PubMed Web of Science ®Google Scholar
• Mathieu, E.-L., M. Belhocine, L. Dao, D. Puthier, and S. Spicuglia. 2014. Functions of lncRNA in development and diseases. médecine/sciences 30 (8-9):790–6. doi: 10.1051/medsci/20143008018.
   Google Scholar
• Matsui, H., M. Motooka, H. Koike, M. Inoue, T. Iwasaki, T. Suzuki, M. Kurabayashi, and T. Yokoyama. 2007. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sciences. 80 (7):672–80. doi: 10.1016/j.lfs.2006.10.027.
   PubMed Web of Science ®Google Scholar
• Matsumura, N., S. Takahara, Z. H. Maayah, N. Parajuli, N. J. Byrne, S. M. Shoieb, C. M. Soltys, D. L. Beker, G. Masson, A. O. S. El-Kadi, et al. 2018. Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites. Journal of Molecular and Cellular Cardiology 125:162–73.
   PubMed Web of Science ®Google Scholar
• Meng, X., J. Zhou, C. N. Zhao, R. Y. Gan, and H. B. Li. 2020. Health benefits and molecular mechanisms of resveratrol: A narrative review. Foods 9 (3):340. doi: 10.3390/foods9030340.
   PubMed Web of Science ®Google Scholar
• Morimoto, T., Y. Sunagawa, T. Kawamura, T. Takaya, H. Wada, A. Nagasawa, M. Komeda, M. Fujita, A. Shimatsu, T. Kita, et al. 2008. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. The Journal of Clinical Investigation 118 (3):868–78.
   PubMed Web of Science ®Google Scholar
• Nabofa, W. E. E., O. O. Alashe, O. T. Oyeyemi, A. F. Attah, A. A. Oyagbemi, T. O. Omobowale, A. A. Adedapo, and A. R. A. Alada. 2018. Cardioprotective effects of curcumin-nisin based poly lactic acid nanoparticle on myocardial infarction in Guinea pigs. Scientific Reports. 8:16649.
   PubMed Web of Science ®Google Scholar
• Nirmala, C., and R. Puvanakrishnan. 1996. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Molecular and Cellular Biochemistry 159 (2):85–93.
   PubMed Web of Science ®Google Scholar
• Okamura, K., W. J. Chung, J. G. Ruby, H. Guo, D. P. Bartel, and E. C. Lai. 2008. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature 453 (7196):803–6.
   PubMed Web of Science ®Google Scholar
• Pang, B., X. T. Yu, Q. Zhou, T. Y. Zhao, H. Wang, C. J. Gu, and X. L. Tong. 2015. Effect of Rhizoma coptidis (Huang Lian) on treating Diabetes Mellitus. Evidence-Based Complementary and Alternative Medicine 2015:1–10. doi: 10.1155/2015/921416.
   Web of Science ®Google Scholar
• Pang, X. F., L. H. Zhang, F. Bai, N. P. Wang, A. Ijaz Shah, R. Garner, and Z. Q. Zhao. 2015. Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart. European Journal of Pharmacology 746:22–30. doi: 10.1016/j.ejphar.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Pan, M. H., T. M. Huang, and J. K. Lin. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition: The Biological Fate of Chemicals 27 (4):486–94.
   PubMed Web of Science ®Google Scholar
• Pan, C., L. Lou, Y. Huo, G. Singh, M. Chen, D. Zhang, A. Wu, M. Zhao, S. Wang, and J. Li. 2011. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Therapeutic Advances in Cardiovascular Disease 5 (2):99–111.
   PubMedGoogle Scholar
• Park, J. H., O. Park, J. H. Cho, B. H. Chen, I. H. Kim, J. H. Ahn, J. C. Lee, B. C. Yan, K. Y. Yoo, C. H. Lee, et al. 2014. Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus. Neurochemical Research 39 (7):1300–12.
   PubMed Web of Science ®Google Scholar
• Penumathsa, S. V., S. Koneru, S. M. Samuel, G. Maulik, D. Bagchi, S. F. Yet, V. P. Menon, and N. Maulik. 2008. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radical Biology & Medicine 45 (7):1027–34. doi: 10.1016/j.freeradbiomed.2008.07.012.
   PubMed Web of Science ®Google Scholar
• Penumathsa, S. V., M. Thirunavukkarasu, S. Koneru, B. Juhasz, L. Zhan, R. Pant, V. P. Menon, H. Otani, and N. Maulik. 2007. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. Journal of Molecular and Cellular Cardiology 42 (3):508–16.
   PubMed Web of Science ®Google Scholar
• Prabhu, S., M. Jainu, K. E. Sabitha, and C. S. Devi. 2006. Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. Journal of Ethnopharmacology 107 (1):126–33.
   PubMed Web of Science ®Google Scholar
• Prince, P. S., and B. Sathya. 2010. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. European Journal of Pharmacology 635 (1-3):142–8. doi: 10.1016/j.ejphar.2010.02.019.
   PubMed Web of Science ®Google Scholar
• Priyadarsini, K. I. 2014. The chemistry of curcumin: From extraction to therapeutic agent. Molecules 19 (12):20091–112. doi: 10.3390/molecules191220091.
   PubMed Web of Science ®Google Scholar
• Punithavathi, V. R., and P. S. Prince. 2009. Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. Chemico-Biological Interactions 181 (3):322–7.
   PubMed Web of Science ®Google Scholar
• Punithavathi, V. R., and P. S. Prince. 2010. Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sciences 86 (5/6):178–84.
   PubMed Web of Science ®Google Scholar
• Punithavathi, V. R., and P. Stanely Mainzen Prince. 2011. The cardioprotective effects of a combination of quercetin and α-tocopherol on isoproterenol-induced myocardial infarcted rats. Journal of Biochemical and Molecular Toxicology 25 (1):28–40.
   PubMed Web of Science ®Google Scholar
• Rahnavard, M., M. Hassanpour, M. Ahmadi, M. Heidarzadeh, H. Amini, M. Z. Javanmard, and M. Nouri. 2019. Curcumin ameliorated myocardial infarction by inhibition of cardiotoxicity in the rat model.
   Google Scholar
• Raj, P., B. M. Aloud, X. L. Louis, L. Yu, S. Zieroth, and T. Netticadan. 2016. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats. The Journal of Nutritional Biochemistry 28:155–63.
   PubMed Web of Science ®Google Scholar
• Ravindranath, V., and N. Chandrasekhara. 1981. Metabolism of curcumin–studies with [3H]curcumin. Toxicology 22 (4):337–44. doi: 10.1016/0300-483X(81)90027-5.
   PubMed Web of Science ®Google Scholar
• Ren, Z. H., Y. H. Tong, W. Xu, J. Ma, and Y. Chen. 2010. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 17 (3-4):212–8.
   PubMed Web of Science ®Google Scholar
• Riba, A., L. Deres, B. Sumegi, K. Toth, and E. Szabados. 2017. Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model 2017:6819281.
   Google Scholar
• Rizk, S. M., S. A. El-Maraghy, and N. N. Nassar. 2014. A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats. PLoS One 9 (12):e114560.
   PubMed Web of Science ®Google Scholar
• Rogers, R. G., and J. S. Otis. 2017. Resveratrol-mediated expression of KLF15 in the ischemic myocardium is associated with an improved cardiac phenotype. Cardiovascular Drugs and Therapy 31 (1):29–38.
   PubMed Web of Science ®Google Scholar
• Rona, G., C. I. Chappel, T. Balazs, and R. Gaudry. 1959. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. A.M.A. archives of Pathology 67 (4):443–55.
   PubMedGoogle Scholar
• Sammeturi, M., A. H. Shaik, S. B. R. Bongu, S. Cheemanapalli, A. Mohammad, and L. D. Kodidhela. 2019. Protective effects of syringic acid, resveratrol and their combination against isoprenaline administered cardiotoxicity in wistar rats. Saudi Journal of Biological Sciences 26 (7):1429–35.
   PubMed Web of Science ®Google Scholar
• Saxena, A., and P. Carninci. 2011. Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs . BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 33 (11):830–9. doi: 10.1002/bies.201100084.
   PubMed Web of Science ®Google Scholar
• Schnabel, R., and S. Blankenberg. 2007. Oxidative stress in cardiovascular disease: Successful translation from bench to bedside? Circulation 116 (12):1338–40. doi: 10.1161/CIRCULATIONAHA.107.728394.
   PubMed Web of Science ®Google Scholar
• Senoner, T., and W. Dichtl. 2019. Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients 11 (9):2090. doi: 10.3390/nu11092090.
   PubMed Web of Science ®Google Scholar
• Shang, Q., H. Xu, and L. Huang. 2012. Tanshinone IIA: A promising natural cardioprotective agent. Evidence-Based Complementary and Alternative Medicine : eCAM 2012:716459. doi: 10.1155/2012/716459.
   PubMed Web of Science ®Google Scholar
• Sharma, R. A., A. J. Gescher, and W. P. Steward. 2005. Curcumin: The story so far. European Journal of Cancer (Oxford, England : 1990) 41 (13):1955–68.
   PubMed Web of Science ®Google Scholar
• Shehzad, A., and Y. Lee. 2010. Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs of the Future 35 (2):113. doi: 10.1358/dof.2010.035.02.1426640.
   Web of Science ®Google Scholar
• Shen, L., Y. Gao, J. Qian, A. Sun, and J. Ge. 2011. A novel mechanism for endothelial progenitor cells homing: The SDF-1/CXCR4-Rac pathway may regulate endothelial progenitor cells homing through cellular polarization. Medical Hypotheses 76 (2):256–8. doi: 10.1016/j.mehy.2010.10.014.
   PubMed Web of Science ®Google Scholar
• Shen, L., and H. F. Ji. 2012. The pharmacology of curcumin: Is it the degradation products? Trends in Molecular Medicine 18 (3):138–44. doi: 10.1016/j.molmed.2012.01.004.
   PubMed Web of Science ®Google Scholar
• Shi, X., M. Sun, H. Liu, Y. Yao, and Y. Song. 2013. Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Letters 339 (2):159–66. doi: 10.1016/j.canlet.2013.06.013.
   PubMed Web of Science ®Google Scholar
• Spinale, F. G., H. Gunasinghe, P. D. Sprunger, J. M. Baskin, and W. C. Bradham. 2002. Extracellular degradative pathways in myocardial remodeling and progression to heart failure. Journal of Cardiac Failure 8 (6 Suppl):S332–S338.
   PubMed Web of Science ®Google Scholar
• Stelzner, T. J., C. H. Welsh, E. Berger, R. G. McCullough, K. Morris, J. E. Repine, and J. V. Weil. 1987. Antiarrhythmic agents diminish thiourea-induced pulmonary vascular protein leak in rats. Journal of Applied Physiology (Bethesda, Md. : 1985) 63 (5):1877–83.
   PubMed Web of Science ®Google Scholar
• Stivala, L. A., M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U. M. Pagnoni, A. Albini, E. Prosperi, et al. 2001. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. The Journal of Biological Chemistry 276 (25):22586–94.
   PubMed Web of Science ®Google Scholar
• Su, C.-C., G.-W. Chen, and J.-G. Lin. 2008. Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells. International Journal of Molecular Medicine 22 (5):613–8.
   PubMed Web of Science ®Google Scholar
• Suman, R. K., M. K. Borde, I. R. Mohanty, U. Maheshwari, and Y. A. Deshmukh. 2016. Myocardial salvaging effects of berberine in experimental diabetes co-existing with myocardial infarction. J Clin Diagn Res 10:Ff13–18.
   PubMed Web of Science ®Google Scholar
• Sunagawa, Y., T. Morimoto, H. Wada, T. Takaya, Y. Katanasaka, T. Kawamura, S. Yanagi, A. Marui, R. Sakata, A. Shimatsu, et al. 2011. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circulation Journal : official Journal of the Japanese Circulation Society 75 (9):2151–9. doi: 10.1253/circj.cj-10-1072.
   PubMed Web of Science ®Google Scholar
• Sunagawa, Y., S. Sono, Y. Katanasaka, M. Funamoto, S. Hirano, Y. Miyazaki, Y. Hojo, H. Suzuki, E. Morimoto, A. Marui, et al. 2014. Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats. Journal of Pharmacological Sciences 126 (4):329–36. doi: 10.1254/jphs.14151FP.
   PubMed Web of Science ®Google Scholar
• Sunagawa, Y., H. Wada, H. Suzuki, H. Sasaki, A. Imaizumi, H. Fukuda, T. Hashimoto, Y. Katanasaka, A. Shimatsu, T. Kimura, et al. 2012. A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats. Biological & Pharmaceutical Bulletin 35 (2):139–44. doi: 10.1248/bpb.35.139.
   PubMed Web of Science ®Google Scholar
• Szekeres, T., M. Fritzer-Szekeres, P. Saiko, and W. Jäger. 2010. Resveratrol and resveratrol analogues–structure-activity relationship. Pharmaceutical Research 27 (6):1042–8.
   PubMed Web of Science ®Google Scholar
• Tan, H. L., K. G. Chan, P. Pusparajah, A. Duangjai, S. Saokaew, T. Mehmood Khan, L. H. Lee, and B. H. Goh. 2016. Rhizoma coptidis: A potential cardiovascular protective agent. Frontiers in Pharmacology 7:362.
   PubMed Web of Science ®Google Scholar
• Tang, G. Y., X. Meng, Y. Li, C. N. Zhao, Q. Liu, and H. B. Li. 2017. Effects of vegetables on cardiovascular diseases and related mechanisms. Nutrients 9 (8):857. doi: 10.3390/nu9080857.
   PubMed Web of Science ®Google Scholar
• Tang, G., L. Peng, G. Qian, S. Wang, H. Hu, X. Zhang, G. Song, M. Yao, and C. Zhai. 2016. WITHDRAWN: Resveratrol increases microRNA-130a expression to promote angiogenesis and improve heart functions in mice after myocardial infarction. Experimental and Molecular Pathology.
   Google Scholar
• Tappia, P. S., T. Hata, L. Hozaima, M. S. Sandhu, V. Panagia, and N. S. Dhalla. 2001. Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Archives of Biochemistry and Biophysics 387 (1):85–92.
   PubMed Web of Science ®Google Scholar
• Tian, X. H., and J. H. Wu. 2013. Tanshinone derivatives: A patent review. Expert Opinion on Therapeutic Patents 23 (1):19–29.
   PubMed Web of Science ®Google Scholar
• Tønnesen, H. H., M. Másson, and T. Loftsson. 2002. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. International Journal of Pharmaceutics 244 (1-2):127–35.
   PubMed Web of Science ®Google Scholar
• Tsang, A., D. J. Hausenloy, M. M. Mocanu, and D. M. Yellon. 2004. Postconditioning: A form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circulation Research 95 (3):230–2. doi: 10.1161/01.RES.0000138303.76488.fe.
   PubMed Web of Science ®Google Scholar
• Tse, A. K., K. Y. Chow, H. H. Cao, C. Y. Cheng, H. Y. Kwan, H. Yu, G. Y. Zhu, Y. C. Wu, W. F. Fong, and Z. L. Yu. 2013. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand. The Journal of Biological Chemistry 288 (41):29923–33. doi: 10.1074/jbc.M113.483909.
   PubMed Web of Science ®Google Scholar
• Vendrov, A. E., N. R. Madamanchi, Z. S. Hakim, M. Rojas, and M. S. Runge. 2006. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circulation Research 98 (10):1254–63.
   PubMed Web of Science ®Google Scholar
• Vovkun, T., P. Yanchuk, L. Shtanova, S. Veselskiy, N. Filimonova, A. Shalamay, and V. Vedmid. 2018. Water-soluble quercetin modulates the choleresis and bile lipid ratio in rats. General Physiology and Biophysics 37 (1):111–20.
   PubMed Web of Science ®Google Scholar
• Wang, J., M.-Q. Dong, M.-L. Liu, D.-Q. Xu, Y. Luo, B. Zhang, L.-L. Liu, M. Xu, P.-T. Zhao, Y.-Q. Gao, et al. 2010. Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats. European Journal of Pharmacology 640 (1–3):129–38. doi: 10.1016/j.ejphar.2010.04.047.
   PubMed Web of Science ®Google Scholar
• Wang, K., X. Feng, L. Chai, S. Cao, and F. Qiu. 2017. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metabolism Reviews. 49 (2):139–57. doi: 10.1080/03602532.2017.1306544.
   PubMed Web of Science ®Google Scholar
• Wang, B., S. M. Haldar, Y. Lu, O. A. Ibrahim, S. Fisch, S. Gray, A. Leask, and M. K. Jain. 2008. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. Journal of Molecular and Cellular Cardiology 45 (2):193–7.
   PubMed Web of Science ®Google Scholar
• Wang, R., Y. Y. Liu, X. Y. Liu, S. W. Jia, J. Zhao, D. Cui, and L. Wang. 2014. Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model. Cellular Physiology and Biochemistry 34 (3):854–64. doi: 10.1159/000366304.
   PubMedGoogle Scholar
• Wang, Y., J. Liu, A. Ma, and Y. Chen. 2015. Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis. International Journal of Clinical and Experimental Medicine 8 (8):14513–9.
   PubMed Web of Science ®Google Scholar
• Wang, K., F. Liu, L.-Y. Zhou, B. Long, S.-M. Yuan, Y. Wang, C.-Y. Liu, T. Sun, X.-J. Zhang, and P.-F. Li. 2014. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circulation Research 114 (9):1377–88. doi: 10.1161/CIRCRESAHA.114.302476.
   PubMed Web of Science ®Google Scholar
• Wang, X., Y. Wang, M. Jiang, Y. Zhu, L. Hu, G. Fan, Y. Wang, X. Li, and X. Gao. 2011. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways. Journal of Ethnopharmacology 135 (3):662–71.
   PubMed Web of Science ®Google Scholar
• Wang, N. P., Z. F. Wang, S. Tootle, T. Philip, and Z. Q. Zhao. 2012. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. British Journal of Pharmacology 167 (7):1550–62.
   PubMed Web of Science ®Google Scholar
• Wang, J. W., and J. Y. Wu. 2010. Tanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue cultures. Applied Microbiology and Biotechnology 88 (2):437–49.
   PubMed Web of Science ®Google Scholar
• Wang, H., Y. J. Yang, H. Y. Qian, Q. Zhang, L. J. Gao, P. Li, T. J. Wang, and S. D. Wang. 2012. Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction. Physiological Research 61 (5):543–9. doi: 10.33549/physiolres.932390.
   PubMed Web of Science ®Google Scholar
• Wang, Y. X., X. J. Yao, and Y. H. Tan. 1994. Effects of berberine on delayed afterdepolarizations in ventricular muscles in vitro and in vivo. Journal of Cardiovascular Pharmacology 23 (5):716–22.
   PubMed Web of Science ®Google Scholar
• Wang, W.-T., H. Ye, P.-P. Wei, B.-W. Han, B. He, Z.-H. Chen, and Y.-Q. Chen. 2016. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. Journal of Hematology & Oncology 9 (1):1–12. doi: 10.1186/s13045-016-0348-0.
   PubMedGoogle Scholar
• Wang, L. H., C. H. Yu, Y. Fu, Q. Li, and Y. Q. Sun. 2011. Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model. Phytotherapy Research 25 (1):33–7. doi: 10.1002/ptr.3097.
   PubMed Web of Science ®Google Scholar
• Wang, Y. X., and Y. M. Zheng. 1997. Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. Journal of Cardiovascular Pharmacology 30 (2):214–22.
   PubMed Web of Science ®Google Scholar
• Wei, B., W. W. Li, J. Ji, Q. H. Hu, and H. Ji. 2014. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats. Atherosclerosis 235 (2):318–27. doi: 10.1016/j.atherosclerosis.2014.05.924.
   PubMed Web of Science ®Google Scholar
• Wei, B., M. G. You, J. J. Ling, L. L. Wei, K. Wang, W. W. Li, T. Chen, Q. M. Du, and H. Ji. 2013. Regulation of antioxidant system, lipids and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats. Atherosclerosis 230 (1):148–56. doi: 10.1016/j.atherosclerosis.2013.07.005.
   PubMed Web of Science ®Google Scholar
• Williams, M. 2013. The Merck Index: An Encyclopedia of chemicals, drugs, and biologicals. 2708 pages. April 2013, $150 with 1‐year free access to The Merck Index Online. Cambridge, UK: Merck & Co., Inc.
   Google Scholar
• Wongcharoen, W.,. S. Jai-Aue, A. Phrommintikul, W. Nawarawong, S. Woragidpoonpol, T. Tepsuwan, A. Sukonthasarn, N. Apaijai, and N. Chattipakorn. 2012. Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. The American Journal of Cardiology 110 (1):40–4.
   PubMed Web of Science ®Google Scholar
• Wu, P., Y. Du, Z. Xu, S. Zhang, J. Liu, N. Aa, and Z. Yang. 2019. Protective effects of sodium tanshinone IIA sulfonate on cardiac function after myocardial infarction in mice. American Journal of Translational Research 11 (1):351–60.
   PubMed Web of Science ®Google Scholar
• Wu, Y., X. Liu, Q. Zhou, C. Huang, X. Meng, F. Xu, and J. Li. 2015. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Toxicology and Applied Pharmacology 289 (2):163–76.
   PubMed Web of Science ®Google Scholar
• Wu, W. Y., and Y. P. Wang. 2012. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacologica Sinica 33 (9):1119–30.
   PubMed Web of Science ®Google Scholar
• Wu, W. Y., H. Yan, X. B. Wang, Y. Z. Gui, F. Gao, X. L. Tang, Y. L. Qin, M. Su, T. Chen, and Y. P. Wang. 2014. Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase. PLoS One 9 (4):e94957. doi: 10.1371/journal.pone.0094957.
   PubMed Web of Science ®Google Scholar
• Xia, J. T., L. Z. Chen, W. H. Jian, K. B. Wang, Y. Z. Yang, W. L. He, Y. L. He, D. Chen, and W. Li. 2014. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. Journal of Translational Medicine 12:33.
   PubMed Web of Science ®Google Scholar
• Xia, Y., and N. G. Frangogiannis. 2007. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflammation & Allergy Drug Targets 6 (2):101–7.
   PubMedGoogle Scholar
• Xiao, J., X. Sheng, X. Zhang, M. Guo, and X. Ji. 2016. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Design, Development and Therapy 10:1267–77.
   PubMed Web of Science ®Google Scholar
• Xin, P., Y. Pan, W. Zhu, S. Huang, M. Wei, and C. Chen. 2010. Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction. European Journal of Pharmacology. 649 (1–3):293–300. doi: 10.1016/j.ejphar.2010.09.036.
   PubMed Web of Science ®Google Scholar
• Xuan, W., B. Wu, C. Chen, B. Chen, W. Zhang, D. Xu, J. Bin, and Y. Liao. 2012. Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*. Critical Care Medicine 40 (11):3026–33.
   PubMed Web of Science ®Google Scholar
• Xu, S., and P. Liu. 2013. Tanshinone II-A: New perspectives for old remedies. Expert Opinion on Therapeutic Patents 23 (2):149–53.
   PubMed Web of Science ®Google Scholar
• Xu, S., Z. Liu, Y. Huang, K. Le, F. Tang, H. Huang, S. Ogura, P. J. Little, X. Shen, and P. Liu. 2012. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation. Translational Research: The Journal of Laboratory and Clinical Medicine 160 (2):114–24. doi: 10.1016/j.trsl.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Xu, X. Y., X. Meng, S. Li, R. Y. Gan, Y. Li, and H. B. Li. 2018. Bioactivity, health benefits, and related molecular mechanisms of curcumin: current progress, challenges, and perspectives. Nutrients 10 (10):1553. doi: 10.3390/nu10101553.
   PubMed Web of Science ®Google Scholar
• Xu, W., J. Yang, and L. M. Wu. 2009. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Die Pharmazie 64 (5):332–6.
   PubMed Web of Science ®Google Scholar
• Yang, Y., W. Duan, Y. Lin, W. Yi, Z. Liang, J. Yan, N. Wang, C. Deng, S. Zhang, Y. Li, et al. 2013. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radical Biology & Medicine 65:667–79.
   PubMed Web of Science ®Google Scholar
• Yan, F-f, Y.-F. Liu, Y. Liu, and Y.-X. Zhao. 2009. Sulfotanshinone sodium injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris. International Journal of Cardiology 135 (2):254–5.
   PubMed Web of Science ®Google Scholar
• Yan, F., X. Sun, and C. Xu. 2018. Protective effects of resveratrol improve cardiovascular function in rats with diabetes. Exp Ther Med 15:1728–34.
   PubMed Web of Science ®Google Scholar
• Yao, Y., and Q. Sun. 2012. Exploration of small non coding RNAs in wheat (Triticum aestivum L.). Plant Molecular Biology 80 (1):67–73.
   PubMed Web of Science ®Google Scholar
• Yao, Q. H., D. Q. Wang, C. C. Cui, Z. Y. Yuan, S. B. Chen, X. W. Yao, J. K. Wang, and J. F. Lian. 2004. Curcumin ameliorates left ventricular function in rabbits with pressure overload: Inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. Biological & Pharmaceutical Bulletin 27 (2):198–202. doi: 10.1248/bpb.27.198.
   PubMed Web of Science ®Google Scholar
• Yuan, X., S. Jing, L. Wu, L. Chen, and J. Fang. 2014. Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia‑reperfusion injury in rats by activating the phosphatidylinositol 3‑kinase pathway. Experimental and Therapeutic Medicine 8 (3):973–7. doi: 10.3892/etm.2014.1820.
   PubMed Web of Science ®Google Scholar
• Yu, L., Q. Li, B. Yu, Y. Yang, Z. Jin, W. Duan, G. Zhao, M. Zhai, L. Liu, D. Yi, et al. 2016. Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: Role of silent information regulator 1. Oxidative Medicine and Cellular Longevity 2016:1689602. doi: 10.1155/2016/1689602.
   PubMed Web of Science ®Google Scholar
• Yu, Y., J. Ma, Y. Xiao, Q. Yang, H. Kang, J. Zhen, L. Yu, and L. Chen. 2015. KLF15 is an essential negative regulatory factor for the cardiac remodeling response to pressure overload. Cardiology 130 (3):143–52.
   PubMed Web of Science ®Google Scholar
• Yuping, Y., C. Hua, and Z. Qing. 2018. Advances in the relationship between Kruppel-like factor 15 and cardiovascular disease research. Cardiovascular Endocrinology & Metabolism 7 (2):37–41.
   PubMed Web of Science ®Google Scholar
• Zeng, Z., Y. Pan, W. Wu, L. Li, Z. Wu, Y. Zhang, B. Deng, S. Wei, W. Zhang, F. Lin, et al. 2019. Myocardial hypertrophy is improved with berberine treatment via long non-coding RNA MIAT-mediated autophagy. The Journal of Pharmacy and Pharmacology 71 (12):1822–31.
   PubMed Web of Science ®Google Scholar
• Zhang, W., S. G. Chen, H. S. Ju, S. H. Zhao, C. M. Zou, J. M. Hao, and Y. Liu. 1992. Mechanisms of protective effects of berbamine on ischemia/reperfusion injury in isolated rat heart. Methods and Findings in Experimental and Clinical Pharmacology 14 (9):677–84.
   PubMedGoogle Scholar
• Zhang, X., L. F. Huang, L. Hua, H. K. Feng, and B. Shen. 2019. Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway. European Review for Medical and Pharmacological Sciences 23 (4):1789–96.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., X. J. Ma, C. Y. Guo, M. M. Wang, N. Kou, H. Qu, H. M. Mao, and D. Z. Shi. 2016. Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization. Acta Pharmacologica Sinica 37 (4):463–72.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., L. Wei, D. Sun, F. Cao, H. Gao, L. Zhao, J. Du, Y. Li, and H. Wang. 2010. Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3‐kinase/Akt‐dependent pathway in diabetic rats. Diabetes, Obesity and Metabolism 12 (4):316–22. doi: 10.1111/j.1463-1326.2009.01166.x.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., X. Xiao, M. Li, W. Li, M. Yu, H. Zhang, F. Ping, Z. Wang, and J. Zheng. 2014. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine. BMC Complementary and Alternative Medicine 14:188.
   PubMed Web of Science ®Google Scholar
• Zhao, Z. Q., J. S. Corvera, M. E. Halkos, F. Kerendi, N. P. Wang, R. A. Guyton, and J. Vinten-Johansen. 2003. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. American Journal of Physiology-Heart and Circulatory Physiology 285 (2):H579–588. doi: 10.1152/ajpheart.01064.2002.
   PubMed Web of Science ®Google Scholar
• Zhao, C. N., X. Meng, Y. Li, S. Li, Q. Liu, G. Y. Tang, and H. B. Li. 2017. Fruits for Prevention and Treatment of Cardiovascular Diseases. Nutrients 9 (6):598. doi: 10.3390/nu9060598.
   PubMed Web of Science ®Google Scholar
• Zhao, G. L., L. M. Yu, W. L. Gao, W. X. Duan, B. Jiang, X. D. Liu, B. Zhang, Z. H. Liu, M. E. Zhai, Z. X. Jin, et al. 2016. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacologica Sinica 37 (3):354–67.
   PubMed Web of Science ®Google Scholar
• Zheng, L., M. Liu, M. Wei, Y. Liu, M. Dong, Y. Luo, P. Zhao, H. Dong, W. Niu, Z. Yan, et al. 2015. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents. Respiratory Physiology & Neurobiology 205:120–8. doi: 10.1016/j.resp.2014.09.025.
   PubMed Web of Science ®Google Scholar
• Zhou, X., K. Chan, and J. H. Yeung. 2012. Herb-drug interactions with Danshen (Salvia miltiorrhiza): A review on the role of cytochrome P450 enzymes. Drug Metabolism and Drug Interactions 27 (1):9–18.
   PubMedGoogle Scholar
• Zhou, D.-D., M. Luo, A. Shang, Q.-Q. Mao, B.-Y. Li, R.-Y. Gan, and H.-B. Li. 2021. Antioxidant food components for the prevention and treatment of cardiovascular diseases: effects, mechanisms, and clinical studies. Oxidative Medicine and Cellular Longevity 2021:6627355.
   PubMed Web of Science ®Google Scholar
• Zhu, M. L., Y. L. Yin, S. Ping, H. Y. Yu, G. R. Wan, X. Jian, and P. Li. 2017. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. Clinical and Experimental Hypertension (New York, N.Y. : 1993) 39 (7):672–9.
   PubMed Web of Science ®Google Scholar
• Zhu, X., Y. Yuan, S. Rao, and P. Wang. 2016. LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. European Review for Medical and Pharmacological Sciences 20 (17):3653–60.
   PubMed Web of Science ®Google Scholar